Resultats de la cerca - Matthias A. Karajannis

Refinar resultats
  1. 1
    Neurofibromatosis-related tumors

    Neurofibromatosis-related tumors per Matthias A. Karajannis, Rosalie E. Ferner

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Treatment of pediatric brain tumors

    Treatment of pediatric brain tumors per Matthias A. Karajannis, Jeffrey C. Allen, Elizabeth W. Newcomb

    Publicat 2008
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Glioblastoma multiforme: State of the art and future therapeutics

    Glioblastoma multiforme: State of the art and future therapeutics per DavidH. Harter, TaylorA Wilson, Matthias A. Karajannis

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Strict Lymphotropism of Epstein-Barr Virus During Acute Infectious Mononucleosis in Nonimmunocompromised Individuals

    Strict Lymphotropism of Epstein-Barr Virus During Acute Infectious Mononucleosis in Nonimmunocompromised Individuals per Matthias A. Karajannis, Michael Hummel, I. Anagnostopoulos, H. Stein

    Publicat 1997
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus

    Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus per Wei Li, Jonathan M. Cooper, Matthias A. Karajannis, Filippo G. Giancotti

    Publicat 2012
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma

    R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma per Susan Williams, Matthias A. Karajannis, Luis Chiriboga, John G. Golfinos, Andreas von Deimling, David Zagzag

    Publicat 2010
    Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  7. 7
    Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape

    Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape per Amar Gajjar, Daniel C. Bowers, Matthias A. Karajannis, Sarah Leary, Hendrik Witt, Nicholas G. Gottardo

    Publicat 2015
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Treatment of Pediatric Low-Grade Gliomas

    Treatment of Pediatric Low-Grade Gliomas per Sameer Farouk Sait, Alexandra Giantini-Larsen, Kathryn R. Tringale, Mark M. Souweidane, Matthias A. Karajannis

    Publicat 2023
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors

    Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors per Shiyang Wang, Benjamin Liechty, Seema Patel, Jeffrey S. Weber, Travis J. Hollmann, Matija Snuderl, Matthias A. Karajannis

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma

    ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma per Sylwia Ammoun, Clare H. Cunliffe, Jeffrey C. Allen, Luis Chiriboga, Filippo G. Giancotti, David Zagzag, C. Oliver Hanemann, Matthias A. Karajannis

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation

    Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation per Cordelia Orillac, Cheddhi Thomas, Yosef Dastagirzada, Eveline Teresa Hidalgo, John G. Golfinos, David Zagzag, Jeffrey H. Wisoff, Matthias A. Karajannis, Matija Snuderl

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  12. 12
    MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2

    MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2 per Cheng‐Ying Ho, Eli E. Bar, Caterina Giannini, Luigi Marchionni, Matthias A. Karajannis, David Zagzag, David H. Gutmann, Charles G. Eberhart, Fausto J. Rodriguez

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death

    The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death per Isabelle Petit, Matthias A. Karajannis, Loi͏̈c Vincent, Lauren M. Young, Jason M. Butler, Andrea T. Hooper, Koji Shido, Hermann Steller, David J. Chaplin, Eric J. Feldman, Shahin Rafii

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    <i>BRAF</i>Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549

    <i>BRAF</i>Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549 per Alex Y. Lin, Fausto J. Rodríguez, Matthias A. Karajannis, Susan Williams, Geneviève Legault, David Zagzag, Peter C. Burger, Jeffrey C. Allen, Charles G. Eberhart, Eli E. Bar

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Bevacizumab in recurrent high-grade pediatric gliomas

    Bevacizumab in recurrent high-grade pediatric gliomas per A. Narayana, Saroj Kunnakkat, Jeena Chacko-Mathew, Sharon L. Gardner, Matthias A. Karajannis, Shahzad Raza, Jeffrey H. Wisoff, Howard L. Weiner, David H. Harter, Jeffrey C. Allen

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DCAF1-Mediated Inhibition of the Hippo Pathway Kinases Lats1 and 2 in the Nucleus

    Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DCAF1-Mediated Inhibition of the Hippo Pathway Kinases Lats1 and 2 in the Nucleus per Wei Li, Jonathan M. Cooper, Lü Zhou, Chenyi Yang, Hediye Erdjument‐Bromage, David Zagzag, Matija Snuderl, Marc Ladanyi, C. Oliver Hanemann, Pengbo Zhou, Matthias A. Karajannis, Filippo G. Giancotti

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target

    Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target per Marianne Hütt-Cabezas, Matthias A. Karajannis, David Zagzag, Smit Shah, Iren Horkayne‐Szakaly, Elisabeth J. Rushing, J. Douglas Cameron, Deepali Jain, Charles G. Eberhart, Eric H. Raabe, Fausto J. Rodríguez

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas

    Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas per Matthias A. Karajannis, Geneviève Legault, Mari Hagiwara, Marc Ballas, Krysten Brown, Annette O. Nusbaum, Tsivia Hochman, Judith D. Goldberg, Kevin M. Koch, John G. Golfinos, J. Thomas Roland, Jeffrey C. Allen

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas

    Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas per Matthias A. Karajannis, Geneviève Legault, Mari Hagiwara, Filippo G. Giancotti, Alexander S. Filatov, Anna Derman, Tsivia Hochman, Judith D. Goldberg, Emilio Vega-Gonzales, Jeffrey H. Wisoff, John G. Golfinos, Amanda Merkelson, J. Thomas Roland, Jeffrey C. Allen

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway

    Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alteratio... per Jason T. Huse, Matija Snuderl, David Jones, Carole Brathwaite, Nolan Altman, Ehud Lavi, Richard Saffery, Alexandra Sexton‐Oates, Ingmar Blümcke, David Capper, Matthias A. Karajannis, Ryma Benayed, Lukas Chávez, Cheddhi Thomas, Jonathan Serrano, Laetitia Borsu, Marc Ladanyi, Marc K. Rosenblum

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: